The official launch of the new evaluation report on the London InterCommunity Health Centre's (LIHC) Safer Opioid Supply Program! The goal of the evaluation was to examine and compare self-reported client outcomes from 2022 and 2023. In both years, clients identified reduced use of drugs from unregulated market, reductions in overdose and increased access to health services since starting safer supply. This report also examines which medications (both opioid and stimulant) that participants would like to be prescribed and their preferred mode of administration for SOS medications.
A Q & A session with the speakers followed the presentation.
Also Available
- LIHC Safer Opioid Supply Program September 2023 Evaluation Report: A Comparison of SOS Client Outcomes from 2022 and 2023
- Presentation slide deck
- Previous LIHC evaluation report
- ODPRN's Safer Opioid Supply: A Rapid Review of the Evidence
- CMAJ: Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario
- See our page on safer supply evaluations
- more to come
Our Speakers
Dr. Gillian Kolla PhD is a public health researcher. She uses community-based research to explore how to make harm reduction, health and social services more accessible to people who use drugs. She is currently conducting comparative research on the implementation and scale-up of prescribed safer supply programs in BC and Ontario.
Dr. Andrea Sereda MD is the lead and founding physician for the Safer Opioid Supply (SOS) Program at LIHC, providing pharmaceutical grade opioids to people dependent on the unregulated street supply. As a physician, she cares for people who use drugs, people deprived of housing, and people marginalized from traditional healthcare. She is an avid harm reductionist, practising solidarity with all marginalized peoples, with the goal of eliminating power structures in medicine that perpetuate poor health and oppression.
